{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T03:07:24Z","timestamp":1788923244540,"version":"build-2803163510"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,6,19]],"date-time":"2025-06-19T00:00:00Z","timestamp":1750291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,6,19]],"date-time":"2025-06-19T00:00:00Z","timestamp":1750291200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Pain Headache Rep"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s11916-025-01409-9","type":"journal-article","created":{"date-parts":[[2025,6,19]],"date-time":"2025-06-19T12:25:13Z","timestamp":1750335913000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Trialing Strategies Prior to Intrathecal Drug Delivery in Cancer-Related Pain: A Narrative Review"],"prefix":"10.1007","volume":"29","author":[{"given":"Elizabeth","family":"Roux","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan D.","family":"Kaye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shivam S.","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sahar","family":"Shekoohi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Hao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,19]]},"reference":[{"issue":"12","key":"1409_CR1","doi-asserted-by":"publisher","first-page":"1985","DOI":"10.1093\/annonc\/mdn419","volume":"19","author":"S Deandrea","year":"2008","unstructured":"Deandrea S, Montanari M, Moja L, Apolone G. Prevalence of undertreatment in cancer pain. A review of published literature. Ann Oncol. 2008;19(12):1985\u201391.","journal-title":"Ann Oncol"},{"issue":"7","key":"1409_CR2","doi-asserted-by":"publisher","first-page":"6838","DOI":"10.3390\/curroncol30070500","volume":"30","author":"F Mestdagh","year":"2023","unstructured":"Mestdagh F, Steyaert A, Lavand\u2019homme P. Cancer pain management: A narrative review of current concepts, strategies, and techniques. Curr Oncol Tor Ont. 2023;30(7):6838\u201358.","journal-title":"Curr Oncol Tor Ont"},{"issue":"6","key":"1409_CR3","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.1016\/j.neurom.2021.12.004","volume":"26","author":"C Perruchoud","year":"2023","unstructured":"Perruchoud C, Dupoiron D, Papi B, Calabrese A, Brogan SE. Management of Cancer-Related pain with intrathecal drug delivery: A systematic review and Meta-Analysis of clinical studies. Neuromodulation Technol Neural Interface. 2023;26(6):1142\u201352.","journal-title":"Neuromodulation Technol Neural Interface"},{"key":"1409_CR4","doi-asserted-by":"publisher","unstructured":"Deer TR, Hayek SM, Grider JS, Pope JE, Brogan SE, Gulati A et al. The Polyanalgesic Consensus Conference (PACC)\u00ae: Updates on Clinical Pharmacology and Comorbidity Management in Intrathecal Drug Delivery for Cancer Pain. Neuromodulation [Internet]. 2024 Sep 19 [cited 2025 Mar 7];0(0). Available from: https:\/\/doi.org\/10.1016\/j.neurom.2024.08.006","DOI":"10.1016\/j.neurom.2024.08.006"},{"key":"1409_CR5","doi-asserted-by":"crossref","unstructured":"Deer TR, Hayek SM, Grider JS, Hagedorn JM, McDowell GC, Kim P et al. The Polyanalgesic Consensus Conference (PACC)\u00ae: Intrathecal Drug Delivery Guidance on Safety and Therapy Optimization When Treating Chronic Noncancer Pain. Neuromodulation Technol Neural Interface. 2024;27(7):1107\u201339.","DOI":"10.1016\/j.neurom.2024.03.003"},{"issue":"6","key":"1409_CR6","doi-asserted-by":"publisher","first-page":"1364","DOI":"10.1213\/ANE.0b013e31828d670e","volume":"116","author":"VT Malhotra","year":"2013","unstructured":"Malhotra VT, Root J, Kesselbrenner J, Njoku I, Cubert K, Gulati A, et al. Intrathecal pain pump infusions for intractable Cancer pain: an algorithm for dosing without a neuraxial trial. Anesth Analg. 2013;116(6):1364\u201370.","journal-title":"Anesth Analg"},{"issue":"1","key":"1409_CR7","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1159\/000048379","volume":"75","author":"R Becker","year":"2001","unstructured":"Becker R, Jakob D, Uhle EI, Riegel T, Bertalanffy H. The significance of intrathecal opioid therapy for the treatment of neuropathic Cancer pain conditions. Stereotact Funct Neurosurg. 2001;75(1):16\u201326.","journal-title":"Stereotact Funct Neurosurg"},{"issue":"6","key":"1409_CR8","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1177\/0269216315570514","volume":"29","author":"A Mitchell","year":"2015","unstructured":"Mitchell A, McGhie J, Owen M, McGinn G. Audit of intrathecal drug delivery for patients with difficult-to-control cancer pain shows a sustained reduction in pain severity scores over a 6-month period. Palliat Med. 2015;29(6):554\u201363.","journal-title":"Palliat Med"},{"issue":"2","key":"1409_CR9","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1111\/j.1525-1403.2009.00206.x","volume":"12","author":"E Reig","year":"2009","unstructured":"Reig E, Abej\u00f3n D. Continuous morphine infusion: A retrospective study of efficacy, safety, and demographic variables. Neuromodulation. 2009;12(2):122\u20139.","journal-title":"Neuromodulation"},{"issue":"5","key":"1409_CR10","doi-asserted-by":"publisher","first-page":"395","DOI":"10.36076\/ppj.2012\/15\/395","volume":"15","author":"D Dupoiron","year":"2012","unstructured":"Dupoiron D, Bore F, Lefebvre-Kuntz D, Brenet O, Debourmont S, Dixmerias F, et al. Ziconotide adverse events in patients with cancer pain: a multicenter observational study of a slow titration, multidrug protocol. Pain Physician. 2012;15(5):395\u2013403.","journal-title":"Pain Physician"},{"issue":"7","key":"1409_CR11","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1089\/jpm.2013.0544","volume":"17","author":"HJ Liu","year":"2014","unstructured":"Liu HJ, Gao XZ, Liu XM, Xia M, Li WY, Jin Y. Effect of intrathecal Dexmedetomidine on spinal morphine analgesia in patients with refractory cancer pain. J Palliat Med. 2014;17(7):837\u201340.","journal-title":"J Palliat Med"},{"issue":"2","key":"1409_CR12","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1177\/1049909115615110","volume":"34","author":"Hjun Liu","year":"2017","unstructured":"Liu Hjun, Li Wyan, Chen H, fei, Cheng Z, qiang, Jin Y. Long-Term intrathecal analgesia with a wireless analgesia pump system in the home care of patients with advanced Cancer. Am J Hosp Palliat Med. 2017;34(2):148\u201353.","journal-title":"Am J Hosp Palliat Med"},{"issue":"12","key":"1409_CR13","first-page":"1758","volume":"12","author":"SE Brogan","year":"2011","unstructured":"Brogan SE, Winter NB. Patient-controlled intrathecal analgesia for the management of breakthrough cancer pain: a retrospective review and commentary. Pain Med Malden Mass. 2011;12(12):1758\u201368.","journal-title":"Pain Med Malden Mass"},{"issue":"4","key":"1409_CR14","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1097\/AAP.0000000000000251","volume":"40","author":"SE Brogan","year":"2015","unstructured":"Brogan SE, Winter NB, Okifuji A. Prospective observational study of patient-Controlled intrathecal analgesia: impact on Cancer-Associated symptoms, breakthrough pain control, and patient satisfaction. Reg Anesth Pain Med. 2015;40(4):369\u201375.","journal-title":"Reg Anesth Pain Med"},{"issue":"4","key":"1409_CR15","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1213\/ANE.0000000000004276","volume":"130","author":"SE Brogan","year":"2020","unstructured":"Brogan SE, Sindt JE, Jackman CM, White J, Wilding V, Okifuji A. Prospective association of serum opioid levels and clinical outcomes in patients with Cancer pain treated with intrathecal opioid therapy. Anesth Analg. 2020;130(4):1035\u201344.","journal-title":"Anesth Analg"},{"issue":"7","key":"1409_CR16","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1111\/ner.12759","volume":"21","author":"D Sayed","year":"2018","unstructured":"Sayed D, Monroe F, Orr WN, Phadnis M, Khan TW, Braun E, et al. Retrospective analysis of intrathecal drug delivery: outcomes, efficacy, and risk for Cancer-Related pain at a high volume academic medical center. Neuromodulation J Int Neuromodulation Soc. 2018;21(7):660\u20133.","journal-title":"Neuromodulation J Int Neuromodulation Soc"},{"issue":"2","key":"1409_CR17","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1213\/ANE.0000000000004425","volume":"130","author":"LM Stearns","year":"2020","unstructured":"Stearns LM, Abd-Elsayed A, Perruchoud C, Spencer R, Hammond K, Stromberg K, et al. Intrathecal drug delivery systems for Cancer pain: an analysis of a prospective, multicenter product surveillance registry. Anesth Analg. 2020;130(2):289\u201397.","journal-title":"Anesth Analg"},{"issue":"9","key":"1409_CR18","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1097\/AJP.0b013e3181565d17","volume":"23","author":"S Mercadante","year":"2007","unstructured":"Mercadante S, Intravaia G, Villari P, Ferrera P, Riina S, David F, et al. Intrathecal treatment in cancer patients unresponsive to multiple trials of systemic opioids. Clin J Pain. 2007;23(9):793\u20138.","journal-title":"Clin J Pain"},{"issue":"1","key":"1409_CR19","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.pain.2011.10.002","volume":"153","author":"I Alicino","year":"2012","unstructured":"Alicino I, Giglio M, Manca F, Bruno F, Puntillo F. Intrathecal combination of Ziconotide and morphine for refractory cancer pain: a rapidly acting and effective choice. Pain. 2012;153(1):245\u20139.","journal-title":"Pain"},{"key":"1409_CR20","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.sjpain.2017.04.073","volume":"16","author":"L Kiehel\u00e4","year":"2017","unstructured":"Kiehel\u00e4 L, Hamunen K, Heiskanen T. Spinal analgesia for severe cancer pain: A retrospective analysis of 60 patients. Scand J Pain. 2017;16:140\u20135.","journal-title":"Scand J Pain"},{"issue":"7","key":"1409_CR21","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1111\/j.1399-6576.2009.01989.x","volume":"53","author":"C Lundborg","year":"2009","unstructured":"Lundborg C, Dahm P, Nitescu P, Biber B. High intrathecal bupivacaine for severe pain in the head and neck. Acta Anaesthesiol Scand. 2009;53(7):908\u201313.","journal-title":"Acta Anaesthesiol Scand"},{"key":"1409_CR22","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.sjpain.2016.10.002","volume":"14","author":"TC Mastenbroek","year":"2017","unstructured":"Mastenbroek TC, Kramp-Hendriks BJ, Kallewaard JW, Vonk JM. Multimodal intrathecal analgesia in refractory cancer pain. Scand J Pain. 2017;14:39\u201343.","journal-title":"Scand J Pain"},{"key":"1409_CR23","doi-asserted-by":"publisher","first-page":"439014","DOI":"10.1155\/2015\/439014","volume":"2015","author":"Y Huang","year":"2015","unstructured":"Huang Y, Li X, Zhu T, Lin J, Tao G. Efficacy and safety of ropivacaine addition to intrathecal morphine for pain management in intractable Cancer. Mediators Inflamm. 2015;2015:439014.","journal-title":"Mediators Inflamm"},{"issue":"11","key":"1409_CR24","doi-asserted-by":"publisher","first-page":"e6354","DOI":"10.1097\/MD.0000000000006354","volume":"96","author":"S Zheng","year":"2017","unstructured":"Zheng S, He L, Yang X, Li X, Yang Z. Evaluation of intrathecal drug delivery system for intractable pain in advanced malignancies. Med (Baltim). 2017;96(11):e6354.","journal-title":"Med (Baltim)"},{"issue":"6","key":"1409_CR25","doi-asserted-by":"publisher","first-page":"2038","DOI":"10.1213\/ANE.0000000000002903","volume":"126","author":"G Carvajal","year":"2018","unstructured":"Carvajal G, Dupoiron D, Seegers V, Lebrec N, Bor\u00e9 F, Dubois PY, et al. Intrathecal drug delivery systems for refractory pancreatic Cancer pain: observational Follow-up study over an 11-Year period in a comprehensive Cancer center. Anesth Analg. 2018;126(6):2038\u201346.","journal-title":"Anesth Analg"},{"issue":"1","key":"1409_CR26","doi-asserted-by":"publisher","first-page":"32","DOI":"10.3344\/kjp.2013.26.1.32","volume":"26","author":"JH Kim","year":"2013","unstructured":"Kim JH, Jung JY, Cho MS. Continuous intrathecal morphine administration for Cancer pain management using an intrathecal catheter connected to a subcutaneous injection port: A retrospective analysis of 22 terminal Cancer patients in Korean population. Korean J Pain. 2013;26(1):32\u20138.","journal-title":"Korean J Pain"},{"issue":"5","key":"1409_CR27","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.jfma.2011.03.005","volume":"111","author":"CP Lin","year":"2012","unstructured":"Lin CP, Lin WY, Lin FS, Lee YS, Jeng CS, Sun WZ. Efficacy of intrathecal drug delivery system for refractory cancer pain patients: a single tertiary medical center experience. J Formos Med Assoc Taiwan Yi Zhi. 2012;111(5):253\u20137.","journal-title":"J Formos Med Assoc Taiwan Yi Zhi"},{"issue":"19","key":"1409_CR28","doi-asserted-by":"publisher","first-page":"4040","DOI":"10.1200\/JCO.2002.02.118","volume":"20","author":"TJ Smith","year":"2002","unstructured":"Smith TJ, Staats PS, Deer T, Stearns LJ, Rauck RL, Boortz-Marx RL, et al. Randomized clinical trial of an implantable drug delivery system compared with comprehensive medical management for refractory cancer pain: impact on pain, drug-related toxicity, and survival. J Clin Oncol Off J Am Soc Clin Oncol. 2002;20(19):4040\u20139.","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"issue":"1","key":"1409_CR29","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1001\/jama.291.1.63","volume":"291","author":"PS Staats","year":"2004","unstructured":"Staats PS, Yearwood T, Charapata SG, Presley RW, Wallace MS, Byas-Smith M, et al. Intrathecal Ziconotide in the treatment of refractory pain in patients with cancer or AIDS: a randomized controlled trial. JAMA. 2004;291(1):63\u201370.","journal-title":"JAMA"},{"issue":"3","key":"1409_CR30","first-page":"520","volume":"18","author":"MM Scanlon","year":"2017","unstructured":"Scanlon MM, Gazelka HM, Moeschler SM, Hoelzer BC, Hooten WM, Bendel MA, et al. Surgical site infections in Cancer patients with intrathecal drug delivery devices. Pain Med Malden Mass. 2017;18(3):520\u20135.","journal-title":"Pain Med Malden Mass"},{"key":"1409_CR31","doi-asserted-by":"publisher","first-page":"2139","DOI":"10.2147\/JPR.S315585","volume":"14","author":"MM Aman","year":"2021","unstructured":"Aman MM, Mahmoud A, Deer T, Sayed D, Hagedorn JM, Brogan SE, et al. The American society of pain and neuroscience (ASPN) best practices and guidelines for the interventional management of Cancer-Associated pain. J Pain Res. 2021;14:2139\u201364.","journal-title":"J Pain Res"},{"issue":"4","key":"1409_CR32","doi-asserted-by":"publisher","first-page":"336","DOI":"10.3344\/kjp.2013.26.4.336","volume":"26","author":"DA Jose","year":"2013","unstructured":"Jose DA, Luciano P, Vicente V, Juan Marcos AS, Gustavo FC. Role of catheter\u2019s position for final results in intrathecal drug delivery. Analysis based on CSF dynamics and specific drugs profiles. Korean J Pain. 2013;26(4):336\u201346.","journal-title":"Korean J Pain"}],"container-title":["Current Pain and Headache Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11916-025-01409-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11916-025-01409-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11916-025-01409-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T21:04:06Z","timestamp":1771275846000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11916-025-01409-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,19]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["1409"],"URL":"https:\/\/doi.org\/10.1007\/s11916-025-01409-9","relation":{},"ISSN":["1531-3433","1534-3081"],"issn-type":[{"value":"1531-3433","type":"print"},{"value":"1534-3081","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,19]]},"assertion":[{"value":"11 June 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 June 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This article is based on previous studies and contains no new studies with human participants or animals performed by any authors.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Guidelines"}},{"value":"ADK is the editor in Chief for CPHRs.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"94"}}